Related references
Note: Only part of the references are listed.Serum HBV RNA predicts HBeAg clearance and seroconversion in patients with chronic hepatitis B treated with nucleos(t)ide analogues
Yang Wang et al.
JOURNAL OF VIRAL HEPATITIS (2022)
Letter to the Editor: The Differences Between the Reverse Transcriptional Efficiency of HBV Pregenomic RNA and Transcriptional Efficiency of HBV Covalently Closed Circular DNA
Hao Liao et al.
HEPATOLOGY (2021)
HBV RNA Profiles in Patients With Chronic Hepatitis B Under Different Disease Phases and Antiviral Therapy
Lung-Yi Mak et al.
HEPATOLOGY (2021)
On-treatment HBV RNA dynamic predicts entecavir-induced HBeAg seroconversion in children with chronic hepatitis B
Yongbin Wu et al.
JOURNAL OF INFECTION (2021)
Pregenomic HBV RNA and Hepatitis B Core-Related Antigen Predict Outcomes in Hepatitis B e Antigen-Negative Chronic Hepatitis B Patients Suppressed on Nucleos(T)ide Analogue Therapy
Ivana Carey et al.
HEPATOLOGY (2020)
Use of HBsAg quantification in the natural history and treatment of chronic hepatitis B
Lung-Yi Mak et al.
HEPATOLOGY INTERNATIONAL (2020)
HBcrAg and pg RNA and the therapeutic effect in HBeAg-positive patients receiving anti-viral therapy, baseline serum HBV-RNA is a powerful predictor of response
Guanghua Ma et al.
JOURNAL OF VIRAL HEPATITIS (2020)
Serum HBV RNA Dynamic and Drug Withdrawal Predictor Value in Patients With Chronic HBV Infection on Long-term Nucleos(t)ide Analogue (NA) Therapy
Yayun Liu et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2020)
Evaluation of HBV serological markers in treatment-naive HBV mono-infected patients and HBV-HIV co-infected patients
Bei Jiang et al.
VIRUS RESEARCH (2020)
Serum HBV RNA quantification: useful for monitoring natural history of chronic hepatitis B infection
Yayun Liu et al.
BMC GASTROENTEROLOGY (2019)
New and Old Biomarkers for Diagnosis and Management of Chronic Hepatitis B Virus Infection
Carla S. Coffin et al.
GASTROENTEROLOGY (2019)
Serum Hepatitis B Virus RNA: A New Potential Biomarker for Chronic Hepatitis B Virus Infection
Shi Liu et al.
HEPATOLOGY (2019)
Performance of serum HBcrAg in chronic hepatitis B patients with 8-year nucleos(t)ide analogs therapy
Meng-Lan Wang et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2019)
Novel developments of hepatitis B: treatment goals, agents and monitoring tools
Lung-Yi Mak et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2019)
Hepatitis B Virus Serum DNA and RNA Levels in Nucleos(t)ide Analog-Treated or Untreated Patients During Chronic and Acute Infection
Emily K. Butler et al.
HEPATOLOGY (2018)
High serum levels of pregenomic RNA reflect frequently failing reverse transcription in hepatitis B virus particles
Kasthuri Prakash et al.
VIROLOGY JOURNAL (2018)
The role of quantitative hepatitis B surface antigen revisited
Markus Cornberg et al.
JOURNAL OF HEPATOLOGY (2017)
RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg
Christine I. Wooddell et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound
Jie Wang et al.
JOURNAL OF HEPATOLOGY (2016)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2012)
Share Paper
